Immunoresponsiveness of patients with rheumatoid arthritis receiving cyclophosphamide or gold salts.
D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology*; D001856:Bone Marrow Examination; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006046:Gold / Q000627:therapeutic use*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D037102:Lectins / Q000494:pharmacology; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008934:Mitogens / Q000494:pharmacology; D012882:Skin Tests
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D037102:Lectins; D008934:Mitogens; D006046:Gold; D003520:Cyclophosphamide